|
Takara Holdings Inc. (Consolidated) |
y-o- y(%) |
Takara Shuzo |
y-o- y(%) |
Takara Shuzo International Group |
y-o- y(%) |
Takara Bio Group |
y-o- y(%) |
Sales to customer |
350,665 |
116.5% |
122,921 |
102.7% |
137,483 |
134.5% |
78,142 |
115.4% |
Cost of sales |
230,723 |
123.1% |
93,645 |
103.0% |
95,088 |
135.8% |
33,377 |
180.5% |
Gross profit |
119,941 |
105.6% |
29,276 |
101.6% |
42,394 |
131.9% |
44,765 |
91.0% |
SG&A expenses |
81,996 |
116.8% |
24,385 |
98.8% |
31,573 |
133.4% |
24,224 |
119.3% |
Operating income |
37,945 |
87.5% |
4,890 |
118.3% |
10,821 |
127.7% |
20,541 |
71.1% |
Non-operating income |
1,678 |
112.5% |
544 |
193.3% |
315 |
106.1% |
363 |
101.5% |
Non-operating expenses |
917 |
56.8% |
567 |
163.6% |
169 |
54.8% |
221 |
27.7% |
Ordinary income |
38,706 |
89.5% |
4,867 |
119.6% |
10,967 |
129.6% |
20,682 |
72.7% |
Extraordinary gain |
1,681 |
36.1% |
63 |
56.9% |
8 |
283.1% |
930 |
20.8% |
Extraordinary loss |
694 |
10.0% |
234 |
17.8% |
68 |
33.8% |
388 |
7.2% |
Income before income taxes and minority interests |
39,692 |
96.9% |
4,696 |
164.2% |
10,907 |
132.0% |
21,224 |
77.1% |
Net income attributable to owners of the parent |
21,206 |
102.1% |
3,237 |
166.2% |
6,434 |
119.9% |
16,012 |
80.7% |
―――― |
―――― |
―――― |
―――― |
―――― |
―――― |
―――― |
―――― |
―――― |
Research and development expenses |
8,949 |
138.0% |
367 |
100.3% |
0 |
- |
8,575 |
140.4% |
Capital expenditures |
14,165 |
87.4% |
2,763 |
154.8% |
4,704 |
557.4% |
6,516 |
49.4% |
Depreciation |
9,118 |
108.2% |
2,467 |
95.3% |
2,043 |
122.0% |
4,050 |
113.9% |
Amortization of goodwill |
998 |
114.1% |
0 |
- |
399 |
106.5% |
599 |
119.8% |
|